The purchase expands GE HealthCare’s radiopharmaceutical capabilities, helping manufacture and distribute time-sensitive ...
Medical meetings often feature important clinical trial results, making them barometers of biotech and pharma companies’ research progress. Here’s a list of conferences to watch for in 2027.
The fundraise is the firm’s largest to date, providing a lift for a European biotech industry that’s fallen further behind ...
The Nobel laureates “laid the foundation” for a new field of brain research, the award committee wrote. Elsewhere, Roche and ...
The deal carries a $1 billion upfront payment and tasks the two companies to develop long-acting antibody drugs that go after ...
Zepbound combination data. Elsewhere, Novo demonstrated continued weight loss following a switch to oral and AbbVie and ...
The latest installment in BioPharma Dive’s data visualization series features a closer look at Kodiak’s stock performance and ...
A former congressman will take over for prominent lobbyist Steve Ubl. Elsewhere, recent buyout deals paid dividends for Mirum and AbbVie.
Children should have the freedom to focus on school, friendships, family, sports, birthdays, and simply growing up. Yet ...
The acquisition of Texas-based IntraBio adds to a growing rare disease business for Shionogi by handing the company a ...
The company’s next-generation shot surpassed Wall Street’s expectations by matching the effectiveness of vaccines from Pfizer ...
The pharma giant cut its partnership after a cancer drug disappointed in testing. Elsewhere, Teva and Samsung Bioepis expanded a partnership and space biotech Varda brought in $251 million.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results